Vision Loss in Older Adults.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  American Family Physician

• Publication date

  2016-08-01

• Fields of study

  Medicine

• Identifiers
  PMID 27479624
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interventions for improving adherence to ocular hypotensive therapy (Review)

  2018cited by this paper
• Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration.

  2017influential reference
• Comprehensive Adult Medical Eye Evaluation Preferred Practice Pattern(®) Guidelines.

  2016cited by this paper
• Screening for Impaired Visual Acuity in Older Adults: US Preventive Services Task Force Recommendation Statement.

  2016cited by this paper
• Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial.

  2016cited by this paper
• Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.

  2015cited by this paper
• Age‐Related Macular Degeneration and Mortality in Older Women: The Study of Osteoporotic Fractures

  2015cited by this paper
• Prevalence of Disability and Disability Type Among Adults — United States, 2013

  2015cited by this paper
• Psychologic adjustment to irreversible vision loss in adults: a systematic review.

  2015cited by this paper
• Anti-vascular endothelial growth factor for neovascular age-related macular degeneration.

  2014influential reference
• Anti-vascular endothelial growth factor for proliferative diabetic retinopathy.

  2014cited by this paper
• Ten-year follow-up of age-related macular degeneration in the age-related eye disease study: AREDS report no. 36.

  2014cited by this paper
• Age-related Eye Disease Study 2: perspectives, recommendations, and unanswered questions

  2014cited by this paper
• Anti-vascular endothelial growth factor for diabetic macular oedema.

  2014cited by this paper
• Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3.

  2014cited by this paper
• A cost-minimization analysis comparing immediate sequential cataract surgery and delayed sequential cataract surgery from the payer, patient, and societal perspectives in the United States.

  2014cited by this paper
• Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration.

  2014cited by this paper
• Laser photocoagulation for proliferative diabetic retinopathy.

  2014cited by this paper
• A review of anti-VEGF agents for proliferative diabetic retinopathy

  2014cited by this paper
• Managed care implications of age-related ocular conditions.

  2013cited by this paper
• Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.

  2013cited by this paper
• Interventions for improving adherence to ocular hypotensive therapy.

  2013cited by this paper
• Lutein/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4.

  2013cited by this paper
• Causes of vision loss worldwide, 1990-2010: a systematic analysis.

  2013cited by this paper
• Fenofibrate - a potential systemic treatment for diabetic retinopathy?

  2012cited by this paper
• Diabetes in Older Adults

  2012cited by this paper
• The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1).

  2012cited by this paper
• The Age-related Eye Disease Study 2 ( AREDS 2 ) Study Design and Baseline Characteristics ( AREDS 2 Report

  2012cited by this paper
• Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration.

  2012cited by this paper
• Routine preoperative medical testing for cataract surgery.

  2012cited by this paper
• An outbreak of streptococcus endophthalmitis after intravitreal injection of bevacizumab.

  2012cited by this paper
• Glaucoma.

  2011cited by this paper
• Effects of medical therapies on retinopathy progression in type 2 diabetes.

  2011cited by this paper
• Ultraviolet Radiation as a Risk Factor for Cataract and Macular Degeneration

  2011cited by this paper
• Long-Term Effects of Intensive Glucose Lowering on Cardiovascular Outcomes

  2011cited by this paper
• Long-term effects of intensive glucose lowering on cardiovascular outcomes.

  2011cited by this paper
• Laser trabeculoplasty for open-angle glaucoma: a report by the american academy of ophthalmology.

  2011cited by this paper
• Effects of smoking on ocular health

  2011cited by this paper
• Visual loss and falls: a review

  2010cited by this paper
• Effects of medical therapies on retinopathy progression in type 2 diabetes.

  2010cited by this paper
• Bevacizumab for neovascular age related macular degeneration (ABC Trial): multicentre randomised double masked study

  2010cited by this paper
• Screening for impaired visual acuity in older adults: U.S. Preventive Services Task Force recommendation statement.

  2009cited by this paper
• Draft Report from the ICD-2 Research Program Task Force

  2009cited by this paper
• 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes

  2009cited by this paper
• Routine preoperative medical testing for cataract surgery.

  2009cited by this paper
• Vision loss in older persons.

  2009cited by this paper
• Adherence and persistence with glaucoma therapy.

  2008cited by this paper
• 10-year follow-up of intensive glucose control in type 2 diabetes.

  2008cited by this paper
• Intravitreal steroids for macular edema in diabetes.

  2008cited by this paper
• Burden and health care resource utilization in neovascular age-related macular degeneration: findings of a multicountry study.

  2007cited by this paper
• Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial.

  2007cited by this paper
• Surgical interventions for age-related cataract.

  2006cited by this paper
• Chapter 5.1 – Age-Related Eye Disease Study (AREDS)

  2006cited by this paper
• Can high-dose supplementation with vitamins C and E, beta carotene, and zinc slow the progression of macular degeneration?

  2002cited by this paper
• The age-related eye disease study (AREDS).

  2002cited by this paper
• The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.

  2002cited by this paper
• UKPDS 50: Risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis

  2001cited by this paper
• A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8.

  2001cited by this paper
• The ocular hypertension treatment study.

  1994cited by this paper

• Global, regional and national burden of glaucoma from 1990 to 2021 and projections to 2050: a retrospective cross-sectional study

  2026cites this paper
• Objective and Subjective Visual Difficulties and Financial Exploitation in Older Adults.

  2025cites this paper
• Global, regional, and national burden of near vision loss in children and adolescents under 20 years from 1990–2021 and prediction to 2060: A cross-sectional study based on the global burden of disease study 2021

  2025cites this paper
• The Power of Vision on Speech Recognition Among Older People.

  2025cites this paper
• Orientation and Mobility of Visually Impaired Individuals Living in Romania

  2025cites this paper
• Prevalence of hypertension and associated factors: a cross-sectional study in Riyadh, Saudi Arabia

  2025cites this paper
• Special users with special needs in autonomous vehicles: A systematic review

  2025cites this paper
• Factors contributing to self-rated health in community-dwelling independent 75-year-old Finns: a population-based cross-sectional cohort study

  2025cites this paper
• Global, regional and national burden of Glaucoma: an update analysis from the Global Burden of Disease Study 2019

  2024cites this paper
• Population-Level Associations Between Visual Impairment and Functional Difficulties in California

  2024cites this paper
• Interpretable diagnostic system for multiocular diseases based on hybrid meta-heuristic feature selection

  2024cites this paper
• Candidate SNP Markers Significantly Altering the Affinity of the TATA-Binding Protein for the Promoters of Human Genes Associated with Primary Open-Angle Glaucoma

  2024cites this paper
• Associations between Plant-Based Dietary Patterns and Sensory Impairments among Chinese Older Adults: Based on the Chinese Longitudinal Healthy Longevity Survey

  2024cites this paper
• Exploring the effects of age and sex on sensory sensitivities in middle and older aged autistic adults.

  2024cites this paper
• Analysis of Elderly Health Status through Intrinsic Capacity Assessment Using the Simple Elderly Screening (SKILAS) Instrument in the Community

  2024cites this paper
• Real-World Performance Benchmarks in the Reading Ability of Prescription Drug Labels by Community-Dwelling Older Adults

  2024cites this paper
• Validity and reliability of food frequency questionnaire used in age-related eye disease studies in Turkish adults

  2023cites this paper
• Is the Health of Older Americans With a GED Equivalent to Their Peers With a High School Diploma?

  2023cites this paper
• A Novel Fusion Deep Learning Approach for Retinal Disease Diagnosis Enhanced by Web Application Predictive Tool

  2023cites this paper
• Aging Hallmarks and Progression and Age-Related Diseases: A Landscape View of Research Advancement

  2023cites this paper
• A Comparison of Night Hazard Detection between Younger and Older Drivers under Driving Simulation and Real-World Conditions

  2023cites this paper
• Triage Acute Vision Changes in the Older Adult as "High Risk".

  2023cites this paper
• Early Detection and Prevention of Age-Related Macular Degeneration

  2023cites this paper
• Alzheimer’s disease: a continuum with visual involvements

  2023cites this paper
• Virtual reality as a means to explore assistive technologies for the visually impaired

  2023cites this paper
• Stem Cells As Potential Regenerative Treatment For Retinal Degenerative Diseases And Diabetic Retinopathy

  2023cites this paper
• Cross-sectional associations of dietary intake with hearing and vision capacities and potential mediation effect of inflammation in older adults: the COGFRAIL study

  2023cites this paper
• Older Adults With Vision Impairment: Living Their Best Life

  2023cites this paper
• Ythdf2 Ablation Protects Aged Retina From RGC Dendrite Shrinking and Visual Decline

  2023cites this paper
• Personalized Font Recommendations: Combining ML and Typographic Guidelines to Optimize Readability

  2022cites this paper
• A Comprehensive Convolutional Neural Network Survey to Detect Glaucoma Disease

  2022cites this paper
• A Microfluidic Eye Facsimile System to Examine the Migration of Stem-like Cells

  2022cites this paper
• Validation of the five‐item version of the Geriatric Depression Scale (GDS‐5) in a Turkish elderly population

  2022cites this paper
• Falls risk screening tools intended to reduce fall risk among independent community-dwelling older adults: A systematic review.

  2022cites this paper
• Delayed anti-VEGF injections during the COVID-19 pandemic and changes in visual acuity in patients with three common retinal diseases: A systematic review and meta-analysis

  2022cites this paper
• Exploring and Improving the Accessibility of Data Privacy-related Information for People Who Are Blind or Low-vision

  2022cites this paper
• Primary Care Provider Familiarity and Compliance with Preferred Practice Patterns for Comprehensive Eye Examinations.

  2022cites this paper
• Cell Reprogramming for Regeneration and Repair of the Nervous System

  2022cites this paper
• Classifying Types of Visual Loss Linked With Function to Inform Referral to Vision Rehabilitation for Older Adults in Singapore

  2022cites this paper
• Linear association between aging and decreased blood thiol antioxidant activity in patients with cataract

  2022cites this paper
• Non-Glaucomatous Causes of Decreased Vision in Glaucoma

  2021cites this paper
• Visual Impairment and Objectively Measured Physical Activity in Middle-Aged and Older Adults.

  2021cites this paper
• Socio-demographic characteristics and ocular status of participants attending world glaucoma week screening

  2021cites this paper
• Reprogramming: Emerging Strategies to Rejuvenate Aging Cells and Tissues

  2021cites this paper
• Reported evidence of vitamin E protection against cataract and glaucoma.

  2021cites this paper
• The Effects of Presbyopia on Performance Vision

  2021cites this paper
• Temporal Trends over a Decade in Serious Vision Impairment in a Large, Nationally Representative Population-based Sample of Older Americans: Gender, Cohort and Racial/Ethnic Differences

  2021cites this paper
• Teleophthalmology's Value in Screening for Blinding Eye Diseases

  2021cites this paper
• Ophthalmic conditions associated with dementia risk: The Cardiovascular Health Study

  2021cites this paper
• Laying the foundation for an International Classification of Functioning, Disability and Health Core Set for community-dwelling elderly adults in primary care: the clinical perspective identified in a cross-sectional study

  2020cites this paper
• Fatty Acid Concentration of Serum Phospholipids in Normal and Glaucoma Patients

  2020cites this paper
• Environmental and behavioural interventions for reducing physical activity limitation and preventing falls in older people with visual impairment.

  2020cites this paper
• Ageing and human-system errors in manufacturing: a scoping review

  2020cites this paper
• Contributing ocular comorbidity to end-of-life visual acuity in medically treated glaucoma patients, ocular hypertension and glaucoma suspect patients

  2020cites this paper
• Visual Impairment and Mental Health: Unmet Needs and Treatment Options

  2020cites this paper
• The shift of the paradigm between ageing and diseases

  2020cites this paper
• Associations Between Factors Across Life and One-Legged Balance Performance in Mid and Later Life: Evidence From a British Birth Cohort Study

  2020cites this paper
• Visual Outcomes after Endoscopic Endonasal Transsphenoidal Resection of Pituitary Adenomas: Our Institutional Experience

  2020cites this paper
• Factors Influencing Corneal Biomechanics in Diabetes Mellitus.

  2020cites this paper
• Visual Impairment and Mental Health: Unmet Needs and Treatment Options

  2020cites this paper
• Uptake and pharmacokinetics of cefuroxime in rabbits after intravitreal, intracameral, and topical dosing: relevance to human ocular injection of cefuroxime

  2020cites this paper
• Chronic Illness and Ageing in China

  2020cites this paper
• Correlation of Neck Circumference with Cognitive and Sensory Impairment among people in selected villages of Bhubaneswar

  2020cites this paper
• Repository of proposed pathways and protein–protein interaction networks in age-related macular degeneration

  2020cites this paper
• Microfluidic and Microscale Assays to Examine Regenerative Strategies in the Neuro Retina

  2020cites this paper
• Visual Impairment and Mental Health: Unmet Needs and Treatment Options

  2020cites this paper
• Internet and Health Information Technology Use and Psychological Distress Among Older Adults With Self-Reported Vision Impairment: Case-Control Study

  2019cites this paper
• The influence of ageing and diabetic peripheral neuropathy on posture sway, tremor, and the time to achieve balance equilibrium.

  2019cites this paper
• Epidemiology of Eye Diseases in Monocular Blind Veterans in 19 Provinces of Iran from 2010 to 2016

  2019cites this paper
• Subretinal Fibrosis Detection Using Polarization Sensitive Optical Coherence Tomography

  2019cites this paper
• Pain Perception and Acceptance of Illness in Patients Undergoing Phacoemulsification Cataract Surgery under Drip Anesthesia

  2019cites this paper
• Influence of Visual Feedback on 3-Dimensional Forces in a Drop Jump Landing

  2019cites this paper
• Dual Sensory Loss, Mental Health, and Wellbeing of Older Adults Living in China

  2019cites this paper
• Thermoresponsive Gel Drug Delivery for Retina and Posterior Segment Disease

  2018cites this paper
• Clinical characteristics and causes of visual impairment in a low vision clinic in northern Jordan

  2018cites this paper
• Awareness and Knowledge of Poor Vision among Students in Hail University

  2018cites this paper
• Heuristics and Recommendations for the Design of Mobile Serious Games for Older Adults

  2018cites this paper
• Co-morbidity in Geriatric Patients Attend Elderly Clinic in Al-Yarmouk Teaching Hospital

  2018cites this paper
• Risikofaktoren und Zielwerte in der kardiovaskulären Primär- und Sekundärprävention: Bedeutung für das Glaukom

  2018cites this paper
• Effects of Central and Peripheral Vision Occlusion on Motor Performance during Hand Coordination Tasks

  2017cites this paper
• Epigenetic Treatment of Neurodegenerative Ophthalmic Disorders: An Eye Toward the Future

  2017cites this paper
• The Prevalence of Chronic Conditions and Poor Health Among People With and Without Vision Impairment, Aged ≥65 Years, 2010-2014.

  2017cites this paper
• Impact of Chronic Stress Exposure and Illness Perception on Bio-Functional Age in Overweight and Obese People on the Alteration of The Bio-Functional Age, Bio-Functional Status, And Illness Percep-tion: A Follow-Up Study

  year unknowncites this paper